BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24145548)

  • 1. Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent models.
    Barton C; Kouokam JC; Lasnik AB; Foreman O; Cambon A; Brock G; Montefiori DC; Vojdani F; McCormick AA; O'Keefe BR; Palmer KE
    Antimicrob Agents Chemother; 2014; 58(1):120-7. PubMed ID: 24145548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of the Antiviral Lectin Griffithsin Administered by Different Routes Indicates Multiple Potential Uses.
    Barton C; Kouokam JC; Hurst H; Palmer KE
    Viruses; 2016 Dec; 8(12):. PubMed ID: 27999325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor.
    Cao N; Cai Y; Huang X; Jiang H; Huang Z; Xing L; Lu L; Jiang S; Xu W
    mBio; 2024 May; 15(5):e0074124. PubMed ID: 38587427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The griffithsin dimer is required for high-potency inhibition of HIV-1: evidence for manipulation of the structure of gp120 as part of the griffithsin dimer mechanism.
    Xue J; Hoorelbeke B; Kagiampakis I; Demeler B; Balzarini J; Liwang PJ
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3976-89. PubMed ID: 23752505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies in a Murine Model Confirm the Safety of Griffithsin and Advocate Its Further Development as a Microbicide Targeting HIV-1 and Other Enveloped Viruses.
    Kouokam JC; Lasnik AB; Palmer KE
    Viruses; 2016 Nov; 8(11):. PubMed ID: 27869695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Griffithsin Retains Anti-HIV-1 Potency with Changes in gp120 Glycosylation and Complements Broadly Neutralizing Antibodies PGT121 and PGT126.
    Fischer K; Nguyen K; LiWang PJ
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of individual carbohydrate-binding sites in the function of the potent anti-HIV lectin griffithsin.
    Xue J; Gao Y; Hoorelbeke B; Kagiampakis I; Zhao B; Demeler B; Balzarini J; Liwang PJ
    Mol Pharm; 2012 Sep; 9(9):2613-25. PubMed ID: 22827601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Griffithsin: An Antiviral Lectin with Outstanding Therapeutic Potential.
    Lusvarghi S; Bewley CA
    Viruses; 2016 Oct; 8(10):. PubMed ID: 27783038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Griffithsin has antiviral activity against hepatitis C virus.
    Meuleman P; Albecka A; Belouzard S; Vercauteren K; Verhoye L; Wychowski C; Leroux-Roels G; Palmer KE; Dubuisson J
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5159-67. PubMed ID: 21896910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Griffithsin tandemers: flexible and potent lectin inhibitors of the human immunodeficiency virus.
    Moulaei T; Alexandre KB; Shenoy SR; Meyerson JR; Krumpe LR; Constantine B; Wilson J; Buckheit RW; McMahon JB; Subramaniam S; Wlodawer A; O'Keefe BR
    Retrovirology; 2015 Jan; 12():6. PubMed ID: 25613831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the carbohydrate-binding sites of griffithsin in the prevention of DC-SIGN-mediated capture and transmission of HIV-1.
    Hoorelbeke B; Xue J; LiWang PJ; Balzarini J
    PLoS One; 2013; 8(5):e64132. PubMed ID: 23741304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porcine deltacoronavirus infection is inhibited by Griffithsin in cell culture.
    Tang R; Guo L; Fan Q; Zhang L; Wang Y; Zhang X; Shi D; Wu Y; Shi H; Liu J; Chen J; Feng L
    Vet Microbiol; 2022 Jan; 264():109299. PubMed ID: 34896854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Griffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus.
    Levendosky K; Mizenina O; Martinelli E; Jean-Pierre N; Kizima L; Rodriguez A; Kleinbeck K; Bonnaire T; Robbiani M; Zydowsky TM; O'Keefe BR; Fernández-Romero JA
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7290-8. PubMed ID: 26369967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Griffithsin Inhibits Nipah Virus Entry and Fusion and Can Protect Syrian Golden Hamsters From Lethal Nipah Virus Challenge.
    Lo MK; Spengler JR; Krumpe LRH; Welch SR; Chattopadhyay A; Harmon JR; Coleman-McCray JD; Scholte FEM; Hotard AL; Fuqua JL; Rose JK; Nichol ST; Palmer KE; O'Keefe BR; Spiropoulou CF
    J Infect Dis; 2020 May; 221(Supplement_4):S480-S492. PubMed ID: 32037447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of two high-mannose N-linked glycans on gp120 renders human immunodeficiency virus 1 largely resistant to the carbohydrate-binding agent griffithsin.
    Huang X; Jin W; Griffin GE; Shattock RJ; Hu Q
    J Gen Virol; 2011 Oct; 92(Pt 10):2367-2373. PubMed ID: 21715597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp.
    Mori T; O'Keefe BR; Sowder RC; Bringans S; Gardella R; Berg S; Cochran P; Turpin JA; Buckheit RW; McMahon JB; Boyd MR
    J Biol Chem; 2005 Mar; 280(10):9345-53. PubMed ID: 15613479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding site.
    Alexandre KB; Gray ES; Pantophlet R; Moore PL; McMahon JB; Chakauya E; O'Keefe BR; Chikwamba R; Morris L
    J Virol; 2011 Sep; 85(17):9039-50. PubMed ID: 21697467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae.
    O'Keefe BR; Giomarelli B; Barnard DL; Shenoy SR; Chan PK; McMahon JB; Palmer KE; Barnett BW; Meyerholz DK; Wohlford-Lenane CL; McCray PB
    J Virol; 2010 Mar; 84(5):2511-21. PubMed ID: 20032190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Antifungal Activity of Q-Griffithsin, a Broad-Spectrum Antiviral Lectin.
    Nabeta HW; Kouokam JC; Lasnik AB; Fuqua JL; Palmer KE
    Microbiol Spectr; 2021 Oct; 9(2):e0095721. PubMed ID: 34494857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preformulation Characterization of Griffithsin, a Biopharmaceutical Candidate for HIV Prevention.
    Kramzer LF; Hamorsky KT; Graebing PW; Wang L; Fuqua JL; Matoba N; Lasnik AB; Moncla BJ; Zhang J; Palmer KE; Rohan LC
    AAPS PharmSciTech; 2021 Feb; 22(3):83. PubMed ID: 33625602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.